News Conference News TCT 2024 TRILUMINATE: More Patient Data Reassure on TEER’s Benefits for Severe TR Michael O'Riordan October 29, 2024
News Features Initial US Commercial TriClip Cases Offer Hope, but Reimbursement Still a Big Question L.A. McKeown August 09, 2024
News Conference News TCT 2023 ‘Big Step Forward’ for Transcatheter Tricuspid Valve Replacement: TRISCEND II Michael O'Riordan October 26, 2023
News Daily News Inequities in Mitral, Tricuspid Trials Have Implications Across CV Research Yael L. Maxwell December 12, 2022
News Features TVT 2022 Minorities, Poorer Patients Missing Out on Structural Heart Care Michael O'Riordan June 15, 2022
News Daily News Good Results For TAVI in Bicuspid Valves, but Questions Persist Michael O'Riordan March 08, 2022
News Conference News TCT 2021 Transcatheter Mitral, Tricuspid Valve Replacement Inch Forward Yael L. Maxwell November 06, 2021
News Features Roughly 80% of ESC Guideline Writers Have Financial COIs Michael O'Riordan April 01, 2021
News Daily News MitraClip in the US: As Coverage Update Looms, Some Questions for REPAIR MR Shelley Wood January 24, 2020
News Conference News TCT 2019 Transcatheter Options Best for Tricuspid Regurgitation in Matched Registry Analysis Michael O'Riordan September 27, 2019
News Daily News Earlier Care, More Data Needed to Increase Treatment Success in Tricuspid Regurgitation Yael L. Maxwell August 07, 2019
News Daily News NeuroARC Proposes New Standards for Assessing Neurologic Damage in CV Clinical Trials Caitlin E. Cox February 07, 2017
News Conference News ACC 2014 Melody Valve Post-Approval Study Demonstrates Results Better than Originally Predicted Yael L. Maxwell March 30, 2014